Rivera, Ambrosio M.
HRN: 02-89-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/08/2024
07/14/2024
IV
500mg
Q8
Peptic Ulcer Diseases
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes